🚧 In aanbouw — Gegevens kunnen onnauwkeurig zijn. We voegen actief meer bedrijven en statistieken toe.

Regeneron Pharmaceuticals, Inc. vs Cintas Corporation

Vergelijking van marktkapitalisatie in de tijd

Regeneron Pharmaceuticals, Inc.

$68.6B

Rang #236

Cintas Corporation

$72.6B

Rang #231

Marktkapitalisatie in de tijd

Belangrijke momenten

  • Regeneron Pharmaceuticals, Inc. streefde Cintas Corporation voorbij tegen 1995
  • Cintas Corporation streefde Regeneron Pharmaceuticals, Inc. voorbij tegen 1997
  • Regeneron Pharmaceuticals, Inc. streefde Cintas Corporation voorbij tegen 2008
  • Cintas Corporation streefde Regeneron Pharmaceuticals, Inc. voorbij tegen 2026

Jaar-op-jaarvergelijking

JaarRegeneron Pharmaceuticals, Inc.Cintas CorporationKoploper
2026$68.6B$72.6BCintas Corporation
2025$79.3B$74.9BRegeneron Pharmaceuticals, Inc.
2024$72.8B$72.1BRegeneron Pharmaceuticals, Inc.
2023$89.7B$59.0BRegeneron Pharmaceuticals, Inc.
2022$73.7B$43.8BRegeneron Pharmaceuticals, Inc.
2021$64.5B$42.5BRegeneron Pharmaceuticals, Inc.
2020$49.4B$33.6BRegeneron Pharmaceuticals, Inc.
2019$38.4B$25.3BRegeneron Pharmaceuticals, Inc.
2018$38.2B$15.7BRegeneron Pharmaceuticals, Inc.
2017$38.4B$14.4BRegeneron Pharmaceuticals, Inc.
2016$37.5B$10.5BRegeneron Pharmaceuticals, Inc.
2015$55.5B$8.2BRegeneron Pharmaceuticals, Inc.
2014$41.9B$7.0BRegeneron Pharmaceuticals, Inc.
2013$28.1B$5.2BRegeneron Pharmaceuticals, Inc.
2012$17.5B$3.5BRegeneron Pharmaceuticals, Inc.
2011$5.7B$2.9BRegeneron Pharmaceuticals, Inc.
2010$3.4B$2.3BRegeneron Pharmaceuticals, Inc.
2009$2.5B$2.1BRegeneron Pharmaceuticals, Inc.
2008$1.9B$1.8BRegeneron Pharmaceuticals, Inc.
2007$2.5B$2.6BCintas Corporation
2006$2.1B$3.0BCintas Corporation
2005$1.6B$3.1BCintas Corporation
2004$941.1M$3.3BCintas Corporation
2003$1.5B$3.7BCintas Corporation
2002$1.9B$3.4BCintas Corporation
2001$2.9B$3.5BCintas Corporation
2000$3.6B$3.9BCintas Corporation
1999$1.3B$2.6BCintas Corporation
1998$753.6M$3.4BCintas Corporation
1997$874.9M$1.9BCintas Corporation
1996$1.6B$1.4BRegeneron Pharmaceuticals, Inc.
1995$1.3B$1.1BRegeneron Pharmaceuticals, Inc.
1994$306.5M$843.8MCintas Corporation